GettyImages - fermentation tank / xijian

Industry insights: Staying ahead in postbiotics

By Olivia Haslam

Gerald Dard, managing director of AB Biotek Human Nutrition and Health (HNH), speaks to NutraIngredients about postbiotic innovation, adaptation, and what’s to come.

Evolva pays €550,000 for Fluxome resveratrol business

Evolva pays €550,000 for Fluxome resveratrol business

By Shane Starling

Swiss biotech firm Evolva has bought failing Fluxome’s, yeast-derived resveratrol business for about €550,000 in cash and shares, but says it has no interest in the remaining omega-3 business being sold by sealed auction.

BLIS K12 decreased the adherence of C. albicans to the petri dish

Probiotic BLIS K12 may protect against oral yeast growth

By Stephen Daniells

Supplements containing the probiotic BLIS K12 ingredient may inhibit the growth of the yeast responsible for oral thrush, suggests new in vitro data that supports the oral health potential of the ingredient.


Follow us


View more


Featured Suppliers